40 results on '"Pellegrini, Costanza"'
Search Results
2. Multicenter comparison of latest-generation balloon-expandable versus self-expanding transcatheter heart valves: Ultra versus Evolut
3. Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromes
4. Systemic inflammatory response syndrome in patients undergoing transcatheter aortic valve implantation.
5. Prognostic impact of anemia and iron-deficiency anemia in a contemporary cohort of patients undergoing transcatheter aortic valve implantation
6. Near-infrared spectroscopy-intravascular ultrasound to improve assessment of coronary artery disease severity in patients referred for transcatheter aortic valve implantation (The IMPACTavi registry): Design and rationale.
7. Subphenotyping of Patients With Aortic Stenosis by Unsupervised Agglomerative Clustering of Echocardiographic and Hemodynamic Data.
8. Feasibility of Coronary Access in Patients With Acute Coronary Syndrome and Previous TAVR.
9. Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves: Comparison of SAPIEN 3 Ultra Versus SAPIEN 3.
10. The Clinical Impact of Psoas Muscle Cross-Sectional Area on Medium-Term Mortality After Transcatheter Aortic Valve Implantation.
11. Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation.
12. Stent Thrombosis in Patients Treated for Acute or Chronic Coronary Syndrome.
13. Multicenter Evaluation of Prosthesis Oversizing of the SAPIEN 3 Transcatheter Heart Valve. Impact on Device Failure and New Pacemaker Implantations.
14. Predictors of Need for Permanent Pacemaker Implantation and Conduction Abnormalities With a Novel Self-expanding Transcatheter Heart Valve.
15. Go with the flow: physiological assessment of coronary artery stenosis severity in patients with severe aortic stenosis.
16. Multicenter Comparison of Novel Self-Expanding Versus Balloon-Expandable Transcatheter Heart Valves.
17. Improvement in Risk Stratification in Transcatheter Aortic Valve Implantation Using a Combination of the Tumor Marker CA125 and the Logistic EuroSCORE.
18. Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With the SAPIEN 3 Balloon-Expandable Transcatheter Heart Valve.
19. Conduction Abnormalities and Pacemaker Implantations After SAPIEN 3 Vs SAPIEN XT Prosthesis Aortic Valve Implantation.
20. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.
21. 1-Year Results After Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves.
22. IMPACT OF EXTRAVALVULAR CARDIAC DAMAGE ON MID-TERM CLINICAL OUTCOME FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH SEVERE AORTIC STENOSIS.
23. TCT-647 Hemodynamic valve deterioration following transcatheter aortic valve implantation: prevalence and predictors of elevated transvalvular gradients.
24. TCT-295 Differential Prognostic Value of Galectin-3 According to Levels of Carbohydrate Antigen 125 in Transcatheter Aortic Valve Implantation.
25. TCT-713 Hemodynamic Valve Dysfunction Following Transcatheter Aortic Valve Implantation: Prevalence and Predictors of Elevated Transvalvular Gradients.
26. TCT-711 Prevalence and Clinical Impact of Bioprosthesis Thrombosis After Transcatheter Aortic Valve Implantation. A Collaborative Meta-Analysis.
27. TCT-496 Outcomes After Transcatheter Aortic Valve Replacement with the SAPIEN 3 - the VARC-2 composite endpoints at one year.
28. MULTICENTER EVALUATION OF PROSTHESIS OVERSIZING FOR THE SAPIEN 3 TRANSCATHETER HEART VALVE – IMPACT ON NEW PACEMAKER IMPLANTATIONS.
29. TCT-692 Unilateral carotid artery occlusion is associated with higher stroke rate after TAVI.
30. TCT-760 Predictors of Elevated Tumor Marker Carbohydrate Antigen 125 in Patients Undergoing Transcatheter Aortic Valve Implantation.
31. TCT-730 A multicenter analysis of incidence and predictors for permanent pacemaker implantations and new conduction abnormalities with a novel self-expandable transcatheter heart valve.
32. TCT-156 Outcomes After Transcatheter Aortic Valve Implantation Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single Center Experience.
33. TCT-230 One-Year Results After Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves: Comparison of SAPIEN 3 Ultra and SAPIEN 3.
34. Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation.
35. Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement.
36. Effects of the coronary artery disease associated LPA and 9p21 loci on risk of aortic valve stenosis.
37. MULTICENTER EVALUATION OF THE ACURATE NEO TRANSFEMORAL TRANSCATHETER HEART VALVE – CLINICAL RESULTS AND PROPENSITY MATCHED COMPARISON WITH SAPIEN 3.
38. TCT-714 Incidental findings in Multislice CT for procedural planning in transcatheter aortic valve implantation: prevalence, clinical relevance and outcome.
39. TCT-337 Multicenter Propensity-Matched Comparison of Latest-Generation Self-Expanding and Balloon-Expandable Transcatheter Heart Valves.
40. CONSCIOUS SEDATION VERSUS GENERAL ANESTHESIA IN TRANSCATHETER AORTIC VALVE REPLACEMENT: THE GERMAN AORTIC VALVE REGISTRY.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.